US Stocks

Matinas BioPharma Holdings, Inc.

Matinas BioPharma Holdings, Inc. specializes in the discovery and development of various product candidates using its lipid nanocrystal platform technology. Their LNC delivery technology utilizes lipid nano-crystals for the delivery of a range of treatments, including small molecules, nucleic acids, gene therapies, vaccines, proteins, and peptides. The company's lead product candidate is LYPDISO, a prescription-only omega-3 free fatty acid-based composition used to treat cardiovascular and metabolic conditions, with other promising products in the pipeline.